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After water, lipids are the most common biomolecules found in the brain (12%). A brief perusal
of the physiology, anatomy, and pathophysiology of the brain illustrates the importance of
lipids. Recent advances in mass spectrometry have allowed the direct probing of tissues.
However, most studies have focused on proteins. In the present work, matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) and MALDI-ion
mobility (IM)-TOFMS were employed for direct analysis of phospholipids in rat brain tissue.
Molecular ions (MH) corresponding to phosphatidylcholines, phosphatidylethanolamines,
and sphingomyelin, were recorded. When studying pharmacology, we learn that many
therapeutic compounds are stored in the body’s adipose tissue. MALDI-TOFMS and MALDI-
IM-TOFMS were thus used to analyze rat brain tissue with chlorisondamine added directly
onto the tissue slice. With both techniques, noncovalent complexes between the tissue
phospholipids and chlorisondamine were detected. In addition, MALDI-IM-TOFMS of non-
covalent complexes between phospholipids and chlorisondamine displayed a mobility
between that of an isobaric lipid and peptide. (J Am Soc Mass Spectrom 2005, 16, 133–138)
© 2004 American Society for Mass SpectrometryPhospholipids represent a major group of lipids,present in abundance in all biological mem-branes. The general structural requirement for
phospholipids is the presence of an alcohol, phosphate,
and a fatty acid chain. However, a quaternary amine is
often present. Major classes of phospholipids include
phosphatidylcholine, phosphatidylethanolamine, phos-
phatidylserine, and sphingomyelin. Lipids, in particu-
lar phospholipids, are a major component of the brain
[1]. Altered levels of phospholipids in tissue are asso-
ciated with Farber disease, Gaucher disease, Niemann-
Pick disease, Alzheimer disease, and Down syndrome
[2–5]. Furthermore, sphingomyelin and other glycolip-
ids have been shown to form noncovalent complexes
with chlorisondamine, a nicotinic antagonist [6, 7], as
well as with acetylcholine and peptides containing two
or more adjacent Arg residues [8]. Traditional methods
for the detection of phospholipids in tissue by mass
spectrometry involve extraction and possible purifica-
tion prior to mass analysis [9]. These sample prepara-
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doi:10.1016/j.jasms.2004.10.002tion steps are time consuming and have to be altered
according to the specific phospholipid to be detected.
Currently, matrix-assisted laser desorption/ioniza-
tion time-of-flight mass spectrometry (MALDI-TOFMS)
is being developed for the direct analysis of large
biomolecules, mainly peptides and proteins, from tissue
[10 –12]. In these studies, MALDI mass spectral profiles
have been generated to map the location of biomol-
ecules or drugs in tissue. MALDI is well-suited for the
direct analysis of biomolecules in tissue because of its
high sensitivity, high tolerance for salts and other
contaminants, and a wide mass range with little frag-
mentation. Despite the success of MALDI for the direct
analysis of peptides and proteins in tissue, very little
work has been undertaken for the direct tissue analysis
of lipids, probably because most of the lipids in tissue
have a molecular weight below 1000 Da, which is a
spectral region that is complicated by chemical noise
and mass interferences from matrix molecular ions. In
addition, identification of lipid analytes can be difficult
because of background interference ions from the prep-
aration of tissue sections, i.e., stains, optimal cutting
temperature compound, etc. However, MALDI was
recently used for the direct analysis of phospholipids in
slices of fresh and fixed lens tissue [13]. In this work,
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sphingomyelins, were studied for regional analysis in
tissue.
Ion mobility (IM) spectrometry is a robust method
that allows for the rapid separation and analysis of a
wide range of compounds [14]. In this technique, ions
can be generated by several methods such as pyrolysis,
electrospray, and laser desorption prior to entering a
gas-filled mobility drift cell region. In the drift cell, ions
obtain an average drift velocity from an electric field
based upon their collision cross section () or shape,
which allows for the separation of different shaped
molecules [14, 15]. The coupling of IM to mass spec-
trometry (IM-MS) has been used for the analysis of a
large variety of samples including explosives, drug
molecules, biomolecules, etc. [16, 17]. Furthermore,
IM-MS has been employed successfully for the analysis
of structural isomers [18]. The combining of a MALDI
source with ion-mobility has allowed for a wide range
of samples to be analyzed by MALDI-IM [19, 20]. In a
recent study, MALDI-IM has been used to analyze
complex mixtures of test biomolecules of known struc-
ture, including sphingomyelin and other lipids [7]. In
that work, isobaric lipid, peptide, and oligonucleotides
were preseparated prior to mass analysis by differences
of up to 30% in ion mobility drift time.
In this work, we report on the direct analysis of
phospholipids in rat brain tissue using conventional
MALDI-TOFMS and MALDI- IM-TOFMS. Nine differ-
ent molecular species of phospholipids, consisting of
phosphatidylcholines, phosphatidylethanolamine, and
sphingomyelin, were identified by determining both
the parent ion m/z and their ion mobility drift times,
which are characteristic of lipid molecules. Direct anal-
ysis of tissue using MALDI-IM-TOFMS resulted in 2-D
mass spectra with separate trend lines corresponding to
lipids, peptides, and oligonucleotides. Brain tissue with
chlorisondamine added was also analyzed by MALDI-
TOFMS and MALDI- IM-TOFMS. In both cases, nonco-
valent complexes were observed between the tissue
phospholipids and chlorisondamine. Furthermore, in
MALDI- IM-TOFMS, these noncovalent complexes ex-
hibited a mobility between that of an isobaric lipid and
peptide.
Experimental
Mass Spectrometers
A Voyager DE-Pro MALDI time-of-flight instrument
(PE-Biosystems, Framingham, MA) was used in this
study for conventional MALDI analysis. A nitrogen
laser (337 nm) at a repetition rate of 3 Hz was employed
for ionization. Samples were analyzed in both linear
and reflectron mode with delayed extraction at an
accelerating voltage of 20 kV. Mass spectra acquired in
linear mode were the sum of 25 laser shots, while mass
spectra acquired in reflectron mode were the sum of 100laser shots. All spectra were acquired in positive ion
mode.
MALDI-IM-TOFMS data were acquired using a pro-
totype periodic focusing ion mobility instrument (Ion-
werks Inc., Houston, TX). A mobility resolution of 30
(FWHM of mobility peak/drift time) and a mass reso-
lution of 2000 for m/z 1000 using an orthogonal time-
of-flight mass spectrometer (o-TOFMS) are routinely
achieved. The length of the drift cell is 15 cm and is
operated at 1600V with 5 torr helium pressure. A
Nd-YLF high repetition rate pulsed UV laser (349 nm,
up to 1 kHz) is used to generate ions. The ions drift to
the end of the mobility cell under the force of a high
voltage field applied between the sample plate and
successive electrode rings within the mobility spec-
trometer. The ions then exit the mobility cell through a
differentially pumped skimmer region into the mass
spectrometer for analysis. The mobility drift times are
typically up to 1 ms, while the flight times within the
mass spectrometer are 25 s or less. Therefore, more
than 400 interleaved mass spectra can be obtained after
every laser pulse depending on the target mass range.
This process is repeated for several hundred laser shots,
until the data contain sufficient intensity to permit
analysis. In this work, the data is presented as 2-D
contour plots of ion intensity as a function of ion
mobility drift time (y-axis) and m/z (x-axis). Further-
more, for each MALDI-IM plot, the derived 1-D ion
mobility spectrum and 1-D mass spectrum are also
included. In the 2-D contour plots of ion mobility versus
mass, compounds that have the same molecular weight
but different structures are observed along ion group-
ings, which have different slopes. In order to highlight
these ion groupings, “trend lines” were added by visual
inspection. All contour plots were produced using IDL
software (Research Systems, Boulder, CO).
Tissue Sectioning
The use and handling of animals in this study abide by
the Guide for the Care and Use of Laboratory Animals
(NIH). Male Spray-Dawley rats (Harlan Industries,
Indianapolis, IN) between 300 and 420 g were used.
Rats were euthanized with sodium pentobarbital intra-
peritoneal injection (65 mg/kg) and were decapitated
upon cessation of respiration. The brains were quickly
removed from the skull and frozen in dry ice-chilled
isopentane for 15 s, prior to storage at 80 °C.
Frozen brain tissue was cut into thin sections (14 m
thickness) in a cryostat (CM 3050 S, Leica Microsystems
Nussloch GmbH, Nussloch, Germany). The tissue sam-
ples were attached to the cryostat sample stages using
ice slush made from distilled water. The ice slush only
came in contact with the tissue blocks at the surface
opposing the sample stages, and was frozen into a thin
layer of ice within 5 s. It was decided to use water
instead of optimal cutting temperature compound
(OCT) to connect the tissue to the sample stage, because
past studies showed that OCT interference can reduce
135J Am Soc Mass Spectrom 2005, 16, 133–138 PHOSPHOLIPIDS IN RAT BRAIN USING MALDIthe quality of the mass spectra [10]. Serial brain sections
were alternately collected onto a MALDI sample target
and poly-L-lysine coated microscopic slide. After col-
lection, tissue sections were stored at 4 °C until MALDI
analysis. The tissue sections on the microscopic slides
were stained with cresyl violet and a Rat Brain Atlas
[21] was used for the assignment of the brain regions
analyzed by mass spectrometry.
Chemicals
Chlorisondamine iodide was acquired from Tocris (St.
Louis, MO) and was diluted in water to a concentration of
1 nmol/L. The following MALDI matrices were used in
this study: 6-aza-2-thiothymine (Aldrich, Milwaukee, WI),
2,6-dihydroxyacetophenone (Fluka, Buchs, Switzerland),
-cyano-4-hydroxy cinnamic acid (Aldrich), and sinapic
acid (Fluka). All matrices were initially prepared as a
saturated solution in 50% ethanol. Upon further testing, a
1:1 (vol/vol) dilution of 6-aza-2-thiothymine or a 1:4 and
1:9 (vol/vol) dilution of 2,6-dihydroxyacetophenone in
50% ethanol were shown to yield optimal mass spectral
results.
Sample Preparation
Matrix solution volumes of 0.1, 0.5, and 1 L were
deposited directly on the tissue section and allowed to
air-dry prior to insertion into the mass spectrometer. For
tissue sections with chlorisondamine, 1, 0.5, or 0.1 L of
the chlorisondamine solution was deposited onto the
tissue and allowed to air-dry. Next, matrix solution was
deposited onto the tissue section and allowed to air-dry
prior to mass analysis.
Results and Discussions
Initial work was conducted to determine the optimal
matrix and matrix concentration for analysis of phospho-
lipids in tissue. Four common MALDI matrices, 6-aza-2-
thiothymine (ATT), 2,6-dihydroxyacetophenone (DHA),
-cyano-4-hydroxy cinnamic acid (CHCA), and sinapic
acid (SA) were tested. From these experiments, it was
determined that a 1:1 (vol/vol) dilution of saturated ATT
solution and a 1:4 and 1:9 (vol/vol) dilution of saturated
DHA solution in 50% ethanol produced the best quality
(signal:noise, low matrix interference peaks, resolution)
mass spectra. Phospholipids were observed using CHCA
and SA, but the quality of the mass spectra and the ability
to identify phospholipid species was difficult due to
matrix interference peaks.
Figure 1 illustrates a typical MALDI mass spectrum of
rat brain tissue in the mass range of the phospholipids
molecular species. This mass spectrumwas obtained from
the cerebral cortex region of the brain in reflectron mode
with DHA matrix. Three different classes of phospholip-
ids: phosphatidylcholines (PC), phosphatidylethano-
lamines (PE), and sphingomyelins (SM), were identified
by direct tissue analysis using MALDI. Table 1 lists all thephospholipid species identified. The most dominant mass
peaks in Figure 1 correspond to the following molecular
species: PC 32:0, PC 34:1, and SM 18:0. Themolecular ions,
[M  H], [M  Na], and [M  K], were observed for
all three species. The domination of the mass spectrum by
peaks associated with PCs and SMs is expected, since
these two classes of phospholipids account for more than
50% of membrane phospholipids in eukariotic organisms
[22]. Furthermore, the presence of a positively charged
quaternary ammonium group in both phosphatidycho-
lines and sphingomyelins aid in the detection of these two
classes of phospholipids in positive ion mode. Previous
MALDI-MS studies of phospolipid mixtures have demon-
strated that in positive ion mode phosphatidylcholine and
sphingomyelin species can inhibit the detection of other
classes of phospholipids at similar concentrations [23, 24].
Several additional regions of the rat brain, including the
hippocampus and hypothalamus, were analyzed by
MALDI-MS. Mass spectral profiles of phospholipids were
similar for the brain regions that were tested. PC 32:0, PC
34:1, and SM 18:0 were the dominant phospholipid spe-
cies detected in all of the brain regions that were analyzed.
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Figure 1. MALDI mass spectrum of the cerebral cortex region
with DHA matrix in reflectron mode.
Table 1. Phospholipid molecular species detected in brain
tissue
Speciesa Protonated molecule (Da)
PC 32:0 734.6
PC 34:0 762.6
PC 34:1 760.6
PC 36:1 788.6
PC 40:6 834.6
PE 38:4 768.6
PE 40:6 792.6
SM 18:0 731.6
SM 24:0 815.7
aPhosphatidylcholine (PC) and phosphatidylethanolamine (PE) species
number equal the total length and number of double bonds of both acyl
chains. Sphingomyelin (SM) species number corresponds to the length
and number of double bonds of the acyl chain attached to the sphin-
gosine base.
136 JACKSON ET AL. J Am Soc Mass Spectrom 2005, 16, 133–138Figure 2 shows a mass spectrum of the cerebral cortex
region in linear mode with ATT matrix. Similar to Figure
1, the major peaks in the mass spectrum correspond to PC
32:0, PC 34:1, and SM 18:0. Note the phospholipid dimers
seen around 1500 Da. Less intense phospholipid dimer
signals were also observed in reflectron mode (see Figure
1). The dimerization of phospholipids has previously been
reported for electrospray ionization mass spectrometry
[25], liquid secondary ion mass spectrometry [26],
MALDI-TOFMS [8], and MALDI-IM-TOFMS [7]. The
three major dimer mass peaks observed in Figure 2
corresponded to the phospholipid species of PC 32:0 and
PC 34:1. Although not labeled on Figure 2, dimer salt
adducts and dimers consisting of SM 18:0 were also
detected.
Chlorisondamine, a nicotinic antagonist, consists of
two quaternary amine groups and a tetrachloroisoindo-
line ring. It has a hydrophobic head and a hydrophilic
body and tail. Previous MALDI mass spectrometry
studies have demonstrated that chlorisondamine forms
noncovalent complexes with sphingomyelin [6, 7]. In
these studies, chlorisondamine and sphingomyelin
were mixed in solution prior to mass analysis. These
complexes consisted of one molecule of chlorisondam-
ine added to sphingomyelin. Additionally, ab initio
calculations of chlorisondamine suggest that the posi-
tively charged quaternary ammonium of chlorisondam-
ine interacts with the phosphate group in sphingomy-
elin [6]. Figure 3 shows a MALDI mass spectrum of rat
brain tissue with 1 nmol of chlorisondamine added.
This mass spectrum was recorded in linear mode with
DHA matrix. Noncovalent complexes between chlor-
isondamine and phosphatidylcholine molecular species
PC32:0 and PC34:1 in the tissue are observed. Both
PC32:0 and PC34:1 form complexes with the addition of
one molecule of chlorisondamine. Additionally, com-
plexes consisting of the addition of one molecule of
chlorisondamine with the loss of (CH3)3N, 59 Da, are
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Figure 2. MALDI mass spectrum of the cerebral cortex region
with ATT matrix in linear mode.also detected. Further experiments were conductedusing ATT, CHCA, and SA matrices. However, only
ATT yielded similar results as seen in Figure 3. This is
in agreement with previous studies of noncovalent
complexes by MALDI in which complex formation was
not observed when highly acidic matrices such as
CHCA were used [27]. Noncovalent complexes were
also observed when 500 and 100 pmol of chlorisondam-
ine were added to tissue sections (data not shown).
MALDI-IM-TOFMS was conducted on rat brain tis-
sue slices onto which chlorisondamine solution was
added. As previously demonstrated using test mole-
cules of known structure, structurally different biomo-
lecular ions, such as lipids, oligonucleotides and pep-
tides form distinct familial trend lines on a 2-D plot of
mobility drift time versus m/z [7]. Furthermore, within a
family of molecules, e.g., peptides, small (few percent)
mobility drift time deviations are observed from a
familial trend line [28]. Comparable studies with lipids
are less well developed [7]; however, the mobility of
lipid ion species is consistently around 12% slower than
isobaric peptides. MALDI-IM-TOFMS of rat brain tissue
section with the addition of 1 nmol chlorisondamine
resulted in mobility-mass spectra with similarly well-
separated trend lines as illustrated in Figure 4a and b.
These lines are not quantitative fits, but are rather
added to guide the eye between major ions within a
molecular class. More detailed studies to define a lipid
familial trend line await an extension of our previous
calibration studies [7] to include more compounds of
known structure. DHA matrix was used for this sample
and, similar to MALDI-TOFMS results above, the dom-
inant phospholipid species identified are PC 32:0, PC
34:1, and SM 18:0. The top trend line in Figure 4a
corresponds to lipids and the phospholipids are clearly
distinguishable, while the bottom trend line corre-
sponds to peptides and fragments. Furthermore, com-
plexes of phospholipids with matrix, with chlorison-
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Figure 3. MALDI mass spectrum of brain tissue with 1 nmol of
chlorisondamine (CHL) added using DHA matrix in linear mode.damine, and with matrix and chlorisondamine are
137J Am Soc Mass Spectrom 2005, 16, 133–138 PHOSPHOLIPIDS IN RAT BRAIN USING MALDIobserved and assigned in analogy to such complexes
previously described using known test molecules of
sphingomyelin [7]. In this previous work, it was shown
that such complexes deviate along a separate trend line
located between the peptide and lipid trend lines as
shown in Figure 4a.
A more detailed view for the mass range below 700 Da
is shown in Figure 4b. Based on our earlier results [7],
trend lines corresponding to lipids, peptides, and oligo-
nucleotides can be identified. In this more restricted mass
region, the trend lines can be approximated by straight
lines [28] and we have added four lines to guide the eye in
Figure 4b. In addition to the lipids and peptides, one can
see that ions peaks which are ascribed to the DHAmatrix,
chlorisondamine and their complexes are consistently
lower in the 2-D plot than the ion peaks in the peptide
trend line. We designated a separate “aromatic” trend line
for these molecular ions with a single benzene ring.
Additionally, chlorisondamine fragments occurring from
the loss of a quaternary amine or the loss of chlorines are
also present along the aromatic trend line.
Figure 4. (a) MALDI-IM 2-D plot of brain tissue with 1 nmol of
chlorisondamine added using DHA matrix. (b) close-up of
MALDI-IM 2-D plot from (a) below 700 Da.The ability to separate different classes of compoundsby ion-mobility prior to mass separation aids in the
identification of analytes in the low-mass region. This is
demonstrated in the identification of the chlorisondamine
molecular ion at 358 Da from a native peptide at 360 Da,
in which the peptide is isobaric with some of the chlor-
isondamine isotopic peaks. The peptide mass peak at 360
Da was observed in blank tissue with no chlorisondamine
present. Figure 5 illustrates a zoomed in view of the
chlorisondamine mobility-mass region from Figure 4b to
which the predicted isotopic distribution of chlorisondam-
ine has been appended. Notice how, despite the overlap of
the peptide mass peak with the chlorisondamine isotopic
peaks, the mobility profile centroid of mass 360 Da is
significantly shifted toward longer mobility times com-
pared with the pure chlorisondamine isotope at 358 Da.
These results show the potential of combined isotopic
resolution and mobility separation as a powerful ap-
proach for drug identification, whichmay reduce the need
for more complicated techniques (e.g., MS/MS) for unam-
biguously determining the presence of drug molecules in
tissue.
Conclusions
Lipids are mostly thought of as biomolecules found in
membranes and other compartmentalizing or protec-
tive layers in the cell. The fact that many therapeutic
compounds interact with the lipid bi-layer, which acts
as a storage area for such bioactive molecules, is often
ignored. In situ analysis of phospholipids from rat brain
tissue sections was performed using both MALDI-
TOFMS and MALDI-IM-TOFMS. Molecular species of
phosphatidylcholine, phospatidylethanolamine, and
sphingomyelin, three major classes of phospholipids
were detected by accurately determining their parent
ion mass and by corroborating their identity as lipid on
the basis of their specific ion mobility. Mass spectra
were dominated by peaks associated with the phospho-
Figure 5. Comparison of mobility-mass region of chlorisondam-
ine from Figure 4 with the predicted isotopic distribution of
chlorisondamine.lipid molecular species PC 32:0, PC 34:1, and SM 18:0.
138 JACKSON ET AL. J Am Soc Mass Spectrom 2005, 16, 133–138Noncovalent complexes between chlorisondamine and
phospholipids were detected in rat brain tissue slices
with chlorisondamine added directly. Direct tissue
analysis with MALDI-IM-TOFMS produced 2-D con-
tour plots of ion mobility time versus m/z with separate
trend lines corresponding to lipids, peptides, drug/
matrix (aromatics), and oligonucleotides. The separa-
tion of chlorisondamine from native biomolecules along
the aromatic trend line allowed for the identification of
chlorisondamine and its fragments. Future studies will
focus on mapping of phospholipid species in brain and
other tissues. Additional studies will include the detec-
tion and mapping of chlorisondamine and other drugs
in tissue from specimens administered to the drug of
interest. In particular, MALDI-IM-TOFMS will be used
because of its ability to separate molecules by class,
which should make the identification of low-molecular
weight drug molecules easier when compared to con-
ventional MALDI-TOFMS.
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